Drugs / RTS,S/AS01B
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT01883609 Comparator | Sep 2013 → Aug 2014 | Plasmodium falciparum malaria | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RTS,S/AS01B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01883609 ↗ |
| Modality | Vaccine | “The RTS,S/AS01 vaccine is a protein (RTS,S) mixed with an adjuvant (AS01).” NCT01883609 ↗ |
| Route | Intramuscular | “Each RTS,S/AS01B dose will be given intramuscularly” NCT01883609 ↗ |